Clinical Trials

A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University